Johnson & Johnson
JNJ
$185.98
-$0.07-0.04%
NYSE
| 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.74B | 21.89B | 22.52B | 22.47B | 22.45B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.74B | 21.89B | 22.52B | 22.47B | 22.45B |
| Cost of Revenue | 7.61B | 7.25B | 6.91B | 6.76B | 6.87B |
| Gross Profit | 16.13B | 14.64B | 15.61B | 15.71B | 15.58B |
| SG&A Expenses | 5.75B | 4.98B | 6.23B | 5.25B | 5.45B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.88B | 15.46B | 18.43B | 16.96B | 15.75B |
| Operating Income | 6.86B | 6.44B | 4.09B | 5.51B | 6.69B |
| Income Before Tax | 6.49B | 13.63B | 3.89B | 3.34B | 5.75B |
| Income Tax Expenses | 954.00M | 2.63B | 456.00M | 644.00M | 1.06B |
| Earnings from Continuing Operations | 5.54B | 11.00B | 3.43B | 2.69B | 4.69B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.54B | 11.00B | 3.43B | 2.69B | 4.69B |
| EBIT | 6.86B | 6.44B | 4.09B | 5.51B | 6.69B |
| EBITDA | 8.81B | 8.21B | 5.98B | 7.36B | 8.48B |
| EPS Basic | 2.30 | 4.57 | 1.41 | 1.12 | 1.95 |
| Normalized Basic EPS | 1.81 | 1.80 | 1.09 | 1.58 | 1.85 |
| EPS Diluted | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 |
| Normalized Diluted EPS | 1.80 | 1.79 | 1.09 | 1.57 | 1.84 |
| Average Basic Shares Outstanding | 2.41B | 2.41B | 2.43B | 2.41B | 2.41B |
| Average Diluted Shares Outstanding | 2.42B | 2.42B | 2.43B | 2.43B | 2.42B |
| Dividend Per Share | 1.30 | 1.24 | 1.24 | 1.24 | 1.24 |
| Payout Ratio | 56.51% | 27.18% | 86.97% | 110.80% | 63.70% |